Sun Pharmaceuticals Industries Reaches All-Time High, Reflecting Strong Performance and Growth Potential
Sun Pharmaceuticals Industries, a leading pharmaceutical company, has reached an all-time high in its stock price on September 29, 2024. According to financial analysis firm MarketsMojo, the stock is currently rated as a 'Buy', indicating confidence in the company's future prospects. The stock has been on an upward trend, outperforming the sector and touching an intraday high of Rs 1959.35. It is also trading higher than its moving averages and has outperformed the Sensex, showcasing its strong performance and growth potential.
Sun Pharmaceuticals Industries, a leading player in the pharmaceuticals and drugs industry, has reached an all-time high in its stock price on September 29, 2024. This is a significant milestone for the company, as it reflects the strong performance and growth potential of the company.
According to MarketsMOJO, a leading financial analysis and research firm, Sun Pharmaceuticals Industries' stock is currently rated as a 'Buy'. This is a positive indication for investors, as it shows the confidence of experts in the company's future prospects.
The stock has been on an upward trend, with today's performance outperforming the sector by 1.4%. This is a testament to the company's strong financials and market position. In fact, Sun Pharmaceuticals Industries has been gaining for the last 2 days and has seen a 4.17% increase in its stock price during this period.
The stock also touched an intraday high of Rs 1959.35, which is a 3.21% increase from its previous close. This further reinforces the company's strong performance and investor confidence.
In terms of moving averages, Sun Pharmaceuticals Industries is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend and suggests that the stock is likely to continue its upward trajectory.
In comparison to the Sensex, Sun Pharmaceuticals Industries has outperformed with a 1-year performance of 70.94%, while the Sensex has only seen a 29.42% increase. This further highlights the company's strong performance and growth potential.
Overall, Sun Pharmaceuticals Industries is a top player in the pharmaceuticals and drugs industry, with a strong financial performance and positive market sentiment. With its stock reaching an all-time high, it is a promising investment opportunity for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
